![M. Alexander Shaw](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
M. Alexander Shaw
Nessuna posizione attualmente
Profilo
M.
Alexander Shaw formerly worked at Prolifagen, Inc., as Chief Executive Officer and Nuventra, Inc., as Chief Operating Officer from 2009 to 2021.
Dr. Shaw received his undergraduate degree from Duke University and doctorate degree from Washington State University.
Precedenti posizioni note di M. Alexander Shaw
| Società | Posizione | Fine |
|---|---|---|
Nuventra, Inc.
 Nuventra, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical pharmacology consulting firm | Direttore operativo | 01/10/2021 |
Prolifagen LLC
 Prolifagen LLC BiotechnologyHealth Technology Develops ribonucleic acid therapeutics intended for cardiac tissue regeneration | Amministratore Delegato | - |
Formazione di M. Alexander Shaw
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
5
Relazioni di 1° grado
4
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 4 |
|---|---|
Duke University
 Duke University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Washington State University
 Washington State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Nuventra, Inc.
Nuventra, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical pharmacology consulting firm | Commercial Services |
Prolifagen LLC
Prolifagen LLC BiotechnologyHealth Technology Develops ribonucleic acid therapeutics intended for cardiac tissue regeneration | Health Technology |
